Dr. Krampitz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1501 Trousdale Drive
Building B, Fifth Floor
Burlingame, CA 94010Phone+1 650-652-8787Fax+1 650-652-8770
Summary
- Dr. Geoffrey Krampitz is a surgical oncologist and general surgeon in Burlingame, CA and is affiliated with the Palo Alto Foundation Medical Group at Mills-Peninsula Hospital. He received his MD and PhD from Stanford University School of Medicine. He completed his general surgery residency at Stanford and a fellowship in complex general surgical oncology from the University of Texas MD Anderson Cancer Center. He has been in practice 6 years. He specializes in hepatobiliary surgery and surgical oncology and is experienced in cancer surgery for pancreas, liver, bile duct, gallbladder, stomach, esophagus, small intestine, colon, adrenal, sarcoma, and melanoma. He has more than 20 publications and over 500 citations.
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityResidency, Surgery, 2009 - 2016
- Stanford University School of MedicineClass of 2009
Certifications & Licensure
- CA State Medical License 2010 - 2026
- TX State Medical License 2017 - 2023
- PA State Medical License 2019 - 2021
- American Board of Surgery Surgery
- American Board of Surgery Complex General Surgical Oncology
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- 1 citationsAssociation of Mutant KRAS Alleles With Morphology and Clinical Outcomes in Pancreatic Ductal Adenocarcinoma.Timothy Chao, Zi-Xuan Wang, Wilbur B Bowne, Clifford J Yudkoff, Ava Torjani
Archives of Pathology & Laboratory Medicine. 2024-12-01 - Euglycemic diabetic ketoacidosis (EDKA) after pancreaticoduodenectomy: An under-recognized metabolic abnormality with outcome implications.Cyrus Sholevar, Ava Torjani, Taylor R Kavanagh, Clifford Yudkoff, Kevin Xiao
Surgery. 2023-04-01 - 9 citationsMargin-Positive Pancreatic Ductal Adenocarcinoma during Pancreaticoduodenectomy: Additional Resection Does Not Improve SurvivalRichard Zheng, David Nauheim, Jonathan Bassig, Matthew Chadwick, Christopher W. Schultz
Annals of Surgical Oncology. 2021-03-01
Press Mentions
- Awards Honor Outstanding Education, Patient CareJune 13th, 2016
- Blood Test May Spot Pancreatic Cancer Earlier - US NewsMay 20th, 2014
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: